by editor | Oct 20, 2014 | Clinicians, Participants, Researchers
Possible mechanisms of aspirin discussed ANNOUNCEMENT Melbourne, 20 October 2014: The use of aspirin to prevent cancer will be discussed by experts at a symposium in Melbourne today. Leading healthcare professionals will discuss the scientific evidence for...
by editor | Aug 7, 2014 | Clinicians, Participants, Researchers
Lack of data underscores importance of ASPREE trial A large scientific review revealed that aspirin protected people aged 50-65 against gastrointestinal cancer, but was unable to determine cancer benefits for those aged over 70. International researchers, who analysed...
by editor | May 30, 2014 | Participants
High quality data answers important questions Principal Investigator to the Australian arm of the ASPREE trial, Professor John McNeil says health authorities require a high level of evidence about the balance of benefits and risks of aspirin in healthy people...
by editor | Mar 7, 2014 | Clinicians, Participants
ASPREE PI editorial in this week’s ‘Medical Observer’ ASPREE Principal Investigator in Australia, Professor John McNeil discusses what the findings of ASPREE trial may mean to future health care. “Currently, it is not known if low-grade inflammation is...
by editor | Jul 22, 2013 | Clinicians, Participants, Researchers
Not conclusive – seek medical advice first says ASPREE investigator Healthy people of all ages should consult their GP prior to commencing aspirin for disease prevention. That’s the advice from Professor Mark Nelson in response to new research that...
Recent Comments